Safety reporting in clinical trials: Six core considerations for success
PPD FSP Pharmacovigilance solutions experts delve into the complex and evolving world of safety reporting in clinical trials, uncovering regulatory and ethics challenges that sponsors face.
This webinar provides guidance in navigating the terrain of pharmacovigilance, including regulatory challenges, and a deeper understanding of the pivotal role played by safety reporting in clinical research.
By exploring these considerations, stakeholders in clinical research, from pharmaceutical companies to clinical investigators, gain a comprehensive perspective on the intricacies of safety reporting.
This knowledge equips them to navigate the multifaceted challenges, uphold rigorous standards of patient safety and ensure unwavering adherence to regulatory requirements throughout the clinical trial journey.
Key learning points:
- Insight into delivering safety reporting to investigators
- Considerations when managing multiple clinical vendors
- Achieving compliance in safety reporting
- Find out about country specific nuances in safety reporting
- Guidance on adapting to and navigating electronic reporting requirements
- How to use pharmacovigilance regulatory intelligence as a guide amidst changes in regulation
